Quantitative Proteomics Analysis of COVID-19 Patients

ABSTRACT: Treatment of severe cases of Coronavirus disease 2019 (COVID-19) is extremely important to decrease death and end organ damages. Herein, we performed a proteomic analysis of plasma samples from mild, moderate and sever Covid-19 patients. Analysis revealed differentially expressed proteins and different therapeutic potential targets related to innate immune responses

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Blood Plasma

DISEASE(S): Severe Acute Respiratory Syndrome

SUBMITTER: Bandar Alghanem  

LAB HEAD: Bandar Abdullah Alghanem

PROVIDER: PXD037400 | Pride | 2023-05-02

REPOSITORIES: Pride